Announced Thu, 25 Jun · 11:23 IST
Trading window closed from 1 July 2026 for Q1 results
Compliance View source PDF
SUDEEPPHRM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
-3.9%1-day move
₹850.00
prior close
₹840.35
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-0.1-0.2-0.2-1.2-3.9-0.0-0.5+1.5+2.2-4.2+1.2+2.1——
Up moveDown movePending
AI summary
Sudeep Pharma has closed its trading window from Wednesday, 1 July 2026, until 48 hours after declaring unaudited financial results for the quarter ending 30 June 2026. All designated persons and their immediate relatives are barred from trading in company shares during this period. The board meeting date to approve the Q1 FY27 results will be announced later. This is a routine insider trading compliance measure under SEBI PIT Regulations and indicates results are expected soon.
Likely market impact
Routine compliance; no direct impact on shareholders. Signals Q1 FY27 results declaration is approaching.